These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 27383246
21. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland. Weidmann AE, MacLure K, Marshall S, Gray G, Stewart D. Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039 [Abstract] [Full Text] [Related]
22. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation. Wells KM, Thornley T, Boyd MJ, Boardman HF. Res Social Adm Pharm; 2014 Aug; 10(1):58-71. PubMed ID: 23608701 [Abstract] [Full Text] [Related]
24. Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland. Paudyal V, Hansford D, Cunningham S, Stewart D. Int J Pharm Pract; 2014 Oct; 22(5):319-26. PubMed ID: 24423237 [Abstract] [Full Text] [Related]
27. Issues with prescribed medications in Aboriginal communities: Aboriginal health workers' perspectives. Hamrosi K, Taylor SJ, Aslani P. Rural Remote Health; 2006 Oct; 6(2):557. PubMed ID: 16683907 [Abstract] [Full Text] [Related]
28. An exploratory study of the views of community pharmacy staff on the management of patients with undiagnosed skin problems. Tucker R, Stewart D. Int J Pharm Pract; 2015 Dec; 23(6):390-8. PubMed ID: 25689029 [Abstract] [Full Text] [Related]
29. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies. Hanes CA, Wong KK, Saini B. Res Social Adm Pharm; 2015 Dec; 11(3):412-27. PubMed ID: 25262387 [Abstract] [Full Text] [Related]
30. Drug shortages in large hospitals in Riyadh: a cross-sectional study. AlRuthia YS, AlKofide H, AlAjmi R, Balkhi B, Alghamdi A, AlNasser A, Alayed A, Alshammari M, Alsuhaibani D, Alathbah A. Ann Saudi Med; 2017 Dec; 37(5):375-385. PubMed ID: 28988252 [Abstract] [Full Text] [Related]
32. Burning questions: Exploring the impact of natural disasters on community pharmacies. Mak PW, Singleton J. Res Social Adm Pharm; 2017 Dec; 13(1):162-171. PubMed ID: 26846908 [Abstract] [Full Text] [Related]
35. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease. Puspitasari HP, Aslani P, Krass I. Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140 [Abstract] [Full Text] [Related]
36. Surveillance and uncertainty: community pharmacy responses to over the counter medicine abuse. Cooper R. Health Soc Care Community; 2013 May; 21(3):254-62. PubMed ID: 23320510 [Abstract] [Full Text] [Related]
37. Community pharmacy in Australia: a health hub destination of the future. McMillan SS, Wheeler AJ, Sav A, King MA, Whitty JA, Kendall E, Kelly F. Res Social Adm Pharm; 2013 May; 9(6):863-75. PubMed ID: 23218552 [Abstract] [Full Text] [Related]
38. Prioritising recommendations to advance community pharmacy practice. Hermansyah A, Pitaloka D, Sainsbury E, Krass I. Res Social Adm Pharm; 2018 Dec; 14(12):1147-1156. PubMed ID: 29472012 [Abstract] [Full Text] [Related]
39. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia. Emmerton L. J Am Pharm Assoc (2003); 2009 Dec; 49(1):31-7. PubMed ID: 19196594 [Abstract] [Full Text] [Related]
40. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies. Badreldin HA, Atallah B. Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]